Tadalafil

Product NDC
70518-2972
11-digit product format
705182972
Labeler code
70518
Product ID
70518-2972_d7ace75a-765f-7b03-e053-2a95a90abb93
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tadalafil
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA209167
Marketing category
ANDA
Marketing start
2020-12-16
Marketing end
0000-00-00
Substance
TADALAFIL
Active strength
5 mg/1
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2972-02022-02-10C16284748780-1d6a99b39-8132-a426-e053-dadaa90af4c263be47e7-56d0-4e7a-882c-95a79384da8c
70518-2972-02022-01-28C16284748780-1d6a99b39-8132-a426-e053-dadaa90af4c263be47e7-56d0-4e7a-882c-95a79384da8c

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
70518-2972-07051829720030 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2972-0) 2020-12-160000-00-00NoNoCurrent